Intracellular distribution of anthracyclines in drug resistant cells

Cytotechnology

Volumn 27, Issue 1-3, 1998, Pages 95-111

  Arancia, Giuseppe ^a   Calcabrini, Annarica ^a   Meschini, Stefania ^a   Molinari, Agnese ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Anthracyclines; Doxorubicin; Golgi apparatus; Intracellular transport; Multidrug resistance; Ultrastructure

Indexed keywords

ANTHRACYCLINE; CANCER CHEMOTHERAPY; CHEMOTHERAPY; CONFOCAL MICROSCOPY; DOXORUBICIN; FLOW CYTOMETRY; GLYCOPROTEIN P; GOLGI APPARATUS; LASER MICROSCOPY; MULTIDRUG RESISTANCE; TUMOR CELL;

EID: 0032412788     PISSN: 09209069     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-94-017-2374-9_6     Document Type: Article

References (63)

1. Arancia G, Bordi F, Calcabrini A, Cametti C, Diociaiuti M and Molinari A (1994) Influence of anthracyclinic antibiotics on membranes of human erythrocytes: a combined radiowave electrical conductivity and electron microscopy study. Bioelectrochem. Bioenerg 34: 45-51.
2. Arancia G, Bordi F, Calcabrini A, Diociaiuti M and Molinari A (1995) Ultrastructural and spectroscopic methods in the study of anthracycline-membrane interaction. Pharmacol Res 32: 255-272.
3. Arancia G, Molinari A, Crateri P, Calcabrini A, Silvestri L and Isacchi G (1988) Adriamycin-plasma membrane interaction in human erythrocytes. Fur J Cell Biol 47: 379-387.
4. Baldini N, Scotlandi K, Serra M, Shikita T, Zini N, Ognibene A, Santi S, Ferracini R and Maraldi NM (1995) Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution. Eur J Cell Biol 68: 226-239.
5. Beck WT, Danks MK, Yalowich JC, Zamora JM and Cirtain MC (1989) Different mechanisms of multiple drug resistance in two human leukemic cell lines. In: Mechanisms of Multiple Drug Resistance in Neoplastic Cells (pp. 211-220), Academic Press, New York.
6. Boiocchi M and Toffoli G (1992) Mechanism of multidrug resistance in human tumour cell lines and complete reversion of cellular resistance. Fur J Cancer 28A: 1099-1105.
7. Breuninger LM, Saptarshi P, Gaughan K, Miki T, Chan A, Aaronson SA and Kruh GD (1995) Expression of multidrug resistanceassociated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res 55: 5342-5347.
8. Broxterman HJ, Schurrhuis GJ, Lantelma J, Baak JPA and Pinedo HM (1990) Towards functional screening for multidrug resistant cells in human malignancies. In: Mihich E (ed) Drug Resistance: Mechanism and Reversal (pp. 309-319), John Libbey, CIC, Rome.
9. Calcabrini A, Villa AM, Molinari A, Doglia SM and Arancia G (1997) Influence of N-methylformamide on the intracellular transport of doxorubicin. Fur J Cell Biol 72: 61-69.
10. Chaires JB, Dattagupta N and Crothers DM (1982) Interaction of anthracycline antibiotics and DNA. Biochemistry 21: 3933-3940.
11. Cianfriglia M, Willingham MC, Tombesi M, Scagliotti V, Frasca G and Chersi A (1994) P-glycoprotein mapping. I. Identification of a linear human-specific epitope in the fourth loop of the P-glycoprotein extracellular domain by MM4.17 murine monoclonal antibody to human multi-drug-resistant cells. Int J Cancer 56: 153-160.
12. Coan DE, Wechezack AR, Viggers RF and Sauvage LR (1993) Effect of shear stress upon localization of the Golgi apparatus and microtubule organizing center in isolated cultured endothelial cells. J Cell Sei 104: 1145-1153.
13. Coley HM, Amos WB, Twentyman PR and Workman P (1993) Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localization of anthracyclines in parent and multidrug resistant cell lines. Br J Cancer 67: 1316-1323.
14. Cornwell MM, Pastan I and Gottesman MM (1987) Certain calcium channel blockers bind specifically to multidrug resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem 262: 2166-2170.
15. De Lange JHM, Schipper NW, Schurrhuis GJ, Ten Kate TK, Jan Heijningen Th HM, Pinedo HM, Lankelma J and Baak JPA (1992) Quantification of intracellular doxorubicin distribution in multidrug resistant and sensitive cells by laserscan microscopy and digital image processing. Cytometry 13: 572-576.
16. Diociaiuti M, Molinari A, Calcabrini A and Arancia G (1991a) Electron energy-loss spectroscopy analysis of adriamycinplasma membrane interaction. J Microsc 164: 95-106.
17. Diociaiuti M, Molinari A, Calcabrini A, Arancia G, Isacchi G, Bordi F and Cametti C (1991b) Alteration of the passiveelectrical properties of adriamycin-treated red cell membrane deduced from dielectric spectroscopy. Bioelectrochem Bioenerg 26: 177-192.
18. Diociaiuti M, Calcabrini A, Meschini S and Arancia G (1997) Intracellular mapping of 4'-deoxy-4'-iododoxorubicin in sensitive and multidrug resistant cells by electron spectroscopic imaging. Micron 28: 389-395.
19. Duarte-Karim M, Ruysschaert JM and Hildebrand J (1976) Affinity of adriamycin to phospholipids: a possible explanation for cardiac mitochondrial lesions. Biochim Biophys Acta 71: 658-663.
20. Duffy PM, Hayes MC, Cooper A and Smart CJ (1996) Confocal microscopy of idarubicin localization in sensitive and multidrugresistant bladder cancer cell lines. Br J Cancer 74: 906-909.
21. Fojo A, Akiyama S, Gottesman MM and Pastan I (1985) Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines. Cancer Res 45: 3002-3007.
22. Fragu P, Klijanienko J, Gandia D, Halpern S and Armand JP (1992) Quantitative mapping of 4′-iododeoxyrubicin in metastatic squamous cell carcinoma by secondary ion mass spectroscopy (SIMS) microscopy. Cancer Res 52: 974-977.
23. Frezard F and Garnier-Suillerot A (1991) DNA-containing liposomes as a model for the study of cell membrane permeation by anthracyclines derivatives. Biochemistry 30: 5038-5043.
24. Fritzsche H, Triebel H, Chaires JB, Dattagupta W and Crothers DM (1982) Studies on interaction of anthracyclines antibiotics and DNA. Biochemistry 21: 3940-3946.
25. Gervasoni JE Jr, Fields SZ, Krishna S, Baker MA, Rosado M, Thuraisamy K, Hindenburg AA and Taub RN (1991) Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Cancer Res 51: 4955-4963.
26. Goormaghtigh E and Ruysschaert JM (1984) Anthracycline glycoside-membrane interactions. Biochim Biophys Acta 779: 271-288.
27. Guffy MM, North JA and Burns CP (1984) Effects of cellular fatty acids alteration on adriamycin sensitivity in cultured L1210 murine leukemia cells. Cancer Res 44: 1863-1866.
28. Henry N, Fantine EO, Bolard J and Garnier-Suillerot A (1985) Interaction of adriamycin with negatively charged model membranes: evidence of two types of binding sites. Biochemistry 24: 7085-7092.
29. Hindenburg AA, Gervasoni JE Jr, Krishna S, Stewart VJ, Rosado M, Lutzky J, Bhala K, Baker MA and Taub RN (1989) Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL60 cells. Cancer Res 49: 4607-4614.
30. Huxham HG, Pinedo HM, Schuurhuis GJ and Joenje H (1992) The use of parallel EELS spectral imaging and elemental mapping in the rapid assessment of anti-cancer drug localization. J Microsc 166: 367-380.
31. Keizer HG, Schurrhuis GJ, Broxtermann HJ, Landelma J, Schoonen WGEJ, van Rijn T, Pinedo HJ and Joenje H (1989) Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expressed in cultured SW-1573 human lung tumor cells. Cancer Res 49: 2988-2993.
32. Koh HK (1991) Cutaneous melanoma. New Engl J Med 325: 171-182.
33. Lewis W and Gonzales B (1986) Anthracycline effects on actin and actin containing thin filaments in cultured neonatal rat myocardial cells. Lab Invest 54: 416123.
34. Lothstein L, Wright HM, Sweatman TW and Israel M (1992) N-benzyladriamycin-14-valerate and drug resistance: correlation of anthracycline structural modification with intracellular accumulation and distribution in multidrug resistant cells. Oncol Res 4: 341-347.
35. Meschini S, Molinari A, Calcabrini A, Citro G and Arancia G (1994) Intracellular localization of the antitumour drug adriamycin in living cultured cells: a confocal microscopy study. J Microsc 176: 204-210.
36. Mizuno NS, Zakis B and Decker RW (1975) Binding of daunomycin to DNA and the inhibition of RNA and DNA synthesis. Cancer Res 35: 1542-1546.
37. Molinari A, Calcabrini A, Crateri P and Arancia G (1990) Interaction of anthracyclinic antibiotics with cytoskeletal components of cultured carcinoma cells. Exp Mol Pathol 53: 11-33.
38. Molinari A, Calcabrini A, Crateri P and Arancia G (1991) Effects of daunomycin on the microtubular network: a cytochemical study on a human melanoma cell line. Eur J Cell Biol 54: 291-298.
39. Molinari A, Cianfriglia M, Meschini S, Calcabrini A and Arancia G (1994) P-glycoprotein expression in the Golgi apparatus of multidrug-resistant cells. Int J Cancer 59: 789-795.
40. Molinari A, Calcabrini A, Meschini S, Stringaro A, Del Bufalo D, Cianfriglia M and Arancia G (1998) Detection of P-glycoprotein in the Golgi apparatus of drug-untreated human melanoma cells. Int J Cancer 75: 885-893.
41. Monparler RL, Karon M, Siegel SE and Avila E (1976) Effects of adriamycin on DNA, RNA and protein synthesis in cell free systems and intact cells. Cancer Res 36: 2891-2895.
42. Oth D, Begin M, Bischoff P, Leroux JY, Mercier G and Bruneau C (1987) Induction by adriamycin and mitomycin C of modifications in lipid composition, size distribution, membrane fluidity and permeability of cultured RDM4 lymphoma cells. Biochim Biophys Acta 900: 198-208.
43. Peterson C and Trouet A (1978) Transport and storage of daunorubicin and doxorubicin in cultured fibroblasts. Cancer Res 38: 4645-4649.
44. Rabkin SW and Sunga P (1987) The effects of doxorubicin (adriamycin) on cytoplasmic microtubule system in cardiac cells. J Mol Cell Cardiol 19: 1073-1083.
45. Ralph WE, Marshall B and Darkin S (1983) Anticancer drugs which intercalate DNA: how do they act? TIBS 8: 212-214.
46. Rutherford AV and Willingham MC (1993) Ultrastructural localization of daunomycin in multidrug resistant cells with modulation of the multidrug transporter. J Histochem Cytochem 41: 1573-1577.
47. Saeki T, Ueda K, Tanigawara Y, Hori R and Komano T (1993) Human P-glycoprotein transports cyclosporin A and FK506. J Biol Chem 268: 6077-6080.
48. Safa AR, Glover CJ, Sewell JL, Meyers MB, Biedler JL and Felsted RL (1987) Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blocker. J Biol Chem 262: 7884-7888.
49. Schadendorf D, Makki A, Stahr C, van Dick A, Wanner R, Scheffer GL, Elens MJ, Scheper R and Henz BM (1995) Membrane transport proteins associated with drug resistance expressed in human melanoma. Am J Pathol 147: 1545-1552.
50. Scheper RJ, Broxterman HJ, Scheffer JL, Kaaijk P, Dalton WS, van Heiningen THM, van Kalken CK, Slovack ML, De Vries EGE, van der Valk P, Meijer CJLM and Pinedo HM (1993) Overexpression of a 110 kD vesicular protein in non-P-glycoprotein mediated multidrug resistance. Cancer Res 53: 1475-1479.
51. Schurrhuis GJ, Broxteman HJ, Cervantes A, van Heijningen THM, de Lange JHM, Baak JPA, Pinedo HM and Lankelma J (1989) Quantitative determination of factors contributing to doxorubicin resistance in multidrug-resistant cells. J Natl Cancer Inst 81: 1887-1892.
52. Schurrhuis GJ, Broxteman HJ, de Lange JHM, Pinedo HM, van Heijningen THM, Kuiper CK, Baak JPA and Lankelma J (1991) Larly multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein. Br J Cancer 64: 857-861.
53. Schurrhuis GJ, van Heijningen THM, Cervantes A, Pinedo HM, de Lange JHM, Keizer HG, Broxteman HJ, Baak JPA and Lankelma J (1993) Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumor cells. Br J Cancer 68: 898-908.
54. Sehested M, Skovsgaard T, van Deurs B and Winther-Nielsen H (1987) Increase in nonspecific adsorptive endocytosis in anthracycline- and vinca alkaloid-resistant Ehrlich ascites tumor cell lines. J Natl Cancer Inst 78: 171-179.
55. Seidel A, Hasmann M, Loser R, Bunge A, Schaefer B, Herzig I, Steidtmann K and Dietel M (1995) Intracellular localization, vesicular accumulation and kinetics of daunorubicin in sensitive and multidrug-resistant gastric carcinoma LPG85-257 cells. Wirchows Archiv 426: 249-256.
56. Siegfried J, Kennedy AK, Sartorelli AC and Tritton TR (1983) The role of membranes in the mechanism of action of the antineoplastic agent adriamycin. J Biochem Chem 258: 339-343.
57. Toffoli G, Corona G, Simone F, Gigante M, De Angeli S and Boiocchi M (1996) Cellular pharmacology of idarubicinol in multidrug-resistant LoVo cell lines. Int J Cancer 67: 129-137.
58. Tritton TR and Yee G (1982) The anticancer agent adriamycin can be actively cytotoxic without entering the cells. Science 217: 248-250.
59. White JG, Amos WB and Fordham M (1987). An evaluation of confocal vs conventional imaging of biological structures by fluorescence light microscopy. J Cell Biol 105: 41-48.
60. Willingham MC, Cornwell MM, Cardarelli CO, Gottesman MM and Pastan I (1986) Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effect of verapamil and other drugs. Cancer Res 46: 5941-5946.
61. Willingham MC, Richert ND, Cornwell MM, Tsuruo T, Hamada H, Gottesman MM and Pastan I (1987) Immunocytochemical localization of P170 at the plasma membrane of multidrug-resistant human cells. J Histochem Cytochem 35: 1451-1456.
62. Wilson T (1990). Confocal microscopy. Academic Press Inc, San Diego.
63. Zaman GRL, Versantvoort OHM, Smit JJM, Eijdems EWHM, De Haas M, Smith AJ, Broxterman HJ, Mulder NH, De Vries EGE, Baas F and Borst P (1993) Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 53: 1747-1750.